The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

GMO salmon production begins as first batch of bioengineered eggs arrive at new US facility despite activist opposition

| | May 30, 2019

On a winding road on the outskirts of a small Rust Belt town in eastern Indiana, a fish hatchery is poised to raise the country’s first genetically engineered animal approved for human consumption by the U.S. Food and Drug Administration.

AquaBounty Technologies, a Massachusetts-based biotechnology company, altered the genetic makeup of the Atlantic salmon to include a gene from chinook salmon and DNA sequence from an eel-like species known as an ocean pout. The result is a salmon that grows to market size about twice as fast as its natural counterpart.

The company, which already breeds the salmon in Canada, [had its] first batch of bioengineered eggs … arrive at its indoor facility in Albany, Ind., [on May 29], and the first salmon fillets raised there could appear in U.S. supermarkets in late 2020. AquaBounty’s decision to raise the salmon in Indiana is a landmark moment for the Midwest, a region …. where land-based fish farming operations have struggled mightily to become profitable.

Related article:  Plant scientists: Anti-GMO activism has warped the public's understanding of biotechnology

However, some consumer groups remain fiercely opposed to the production and sale of genetically modified organisms. These organizations have been vocal crusaders against AquaBounty ….

Read full, original article: Indiana salmon hatchery to raise nation’s first genetically modified animal cleared for human consumption

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend